Search for a full or partial Catalog Number, CAS Number or description
CAS Number: 7681-11-0
Product Catalog
93-1930
Potassium › Potassium iodide (99.99%-K) PURATREM| CAS Number: | 7681-11-0 |
| MDL Number: | MFCD00011405 |
| Molecular Formula: | IK |
| Molecular Weight: | 166.01 |
| Chemical Formula: | KI |
| Color and Form: | white pwdr. |
| Note: |
Stability: hygroscopic
Physical Characteristics: melting point 686°C, boiling point 1330°C, density 3.13
| SECTION 1: Product Identification | |
|---|---|
| Chemical Name: | Potassium iodide (99.99%-K) PURATREM |
| Product Number: | 93-1930 |
| CAS Registry Number: | 7681-11-0 |
| Formula: | KI |
| EINECS Number: | 231-659-4 |
| Chemical Family: | metal halide |
| Synonym: | Potassium monoiodide |
| SECTION 2: Composition and Information on Ingredients | ||||
|---|---|---|---|---|
| Ingredient | CAS Number | Percent | ACGIH (TWA) | OSHA (PEL) |
| Title Compound | 7681-11-0 | 100 | no data | no data |
| SECTION 3: Hazards Identification | |
|---|---|
| Emergency Overview: | Irritating to skin, eyes and respiratory tract. May be harmful if swallowed. Prolonged exposure to iodide salts may produce a mild toxic syndrome known as iodism. May cause harm to the unborn child. |
| Primary Routes of Exposure: | Contact with skin and eyes. Inhalation of dust. |
| Eye Contact: | Contact with eyes may causes irritation, redness and pain. |
| Skin Contact: | Causes irritation to skin. Symptoms include redness, itching, and pain, pimples, boils, hives and blisters. |
| Inhalation: | Causes irritation to the respiratory tract. Symptoms may include coughing and shortness of breath. |
| Ingestion: | Large oral doses may cause irritation to the gastrointestinal tract |
| Acute Health Effects: | Irritating to skin, eyes and respiratory tract. |
| Chronic Health Effects: | Chronic ingestion of iodides may produce iodism. Symptoms include skin rash, running nose, headache and irritation of mucous membranes. Some animal studies indicate mutagenic and reproductive effects. |
| NTP: | No |
| IARC: | No |
| OSHA: | No |
| SECTION 4: First Aid Measures | |
|---|---|
| Eye Exposure: | Immediately flush the eyes with copious amounts of water for at least 10-15 minutes. A victim may need assistance in keeping their eye lids open. Get immediate medical attention. |
| Skin Exposure: | Wash the affected area with water. Remove contaminated clothes if necessary. Seek medical assistance if irritation persists. |
| Inhalation: | Remove the victim to fresh air. Closely monitor the victim for signs of respiratory problems, such as difficulty in breathing, coughing, wheezing, or pain. In such cases seek immediate medical assistance. |
| Ingestion: | Seek medical attention immediately. Keep the victim calm. Give the victim water (only if conscious). Induce vomiting only if directed by medical personnel. |
| SECTION 5: Fire Fighting Measures | |
|---|---|
| Flash Point: | not applicable |
| Autoignition Temperature: | none |
| Explosion Limits: | none |
| Extinguishing Medium: | None. Material is non-flammable. |
| Special Fire Fighting Procedures: | No special fire fighting procedures required. |
| Hazardous Combustion and Decomposion Products: | none |
| Unusual Fire or Explosion Hazards: | No unusual fire or explosion hazards. |
| SECTION 6: Accidental Release Measures | |
|---|---|
| Spill and Leak Procedures: | To avoid raising dust, small spills may be mixed with diatomaceous earth, sand, vermiculite or other suitable inert material and swept up. |
| SECTION 7: Handling and Storage | |
|---|---|
| Handling and Storage: | Store solid in a tightly sealed container away from moisture. Handle under a dry atmosphere of air or nitrogen. Prolonged exposure to the atmosphere may degrade the product. |
| SECTION 8: Exposure Controls and Personal Protection | |
|---|---|
| Eye Protection: | Always wear approved safety glasses when handling a chemical substance in the laboratory. |
| Skin Protection: | Wear protective clothing and gloves. Consult with glove manufacturer to determine the proper type of glove. |
| Ventilation: | Material may form a fine dust. If possible, handle the material in an efficient fume hood. |
| Respirator: | If in form of fine dust and ventilation is not available a respirator should be worn. The use of respirators requires a Respirator Protection Program to be in compliance with 29 CFR 1910.134. |
| Additional Protection: | No additional protection required. |
| SECTION 9: Physical and Chemical Properties | |
|---|---|
| Color and Form: | white pwdr. |
| Molecular Weight: | 166.01 |
| Melting Point: | 686°C |
| Boiling Point: | 1330°C |
| Vapor Pressure: | not applicable |
| Specific Gravity: | 3.13 |
| Odor: | none |
| Solubility in Water: | 127.5g/100cc (0°C) |
| SECTION 10: Stability and Reactivity | |
|---|---|
| Stability: | hygroscopic |
| Hazardous Polymerization: | no hazardous polymerization |
| Conditions to Avoid: | contact with moisture |
| Incompatibility: | chlorine, bromine, perchloric acid and oxidizing agents |
| Decomposition Products: | none |
| SECTION 11: Toxicological Information | |
|---|---|
| RTECS Data: | Intravenous (rat); LDLo: 167 mg/kg. Oral (mouse); LDLo: 1862 mg/kg. Intraperitoneal (mouse); LDLo: 1117 mg/kg. Oral (rabbit); LDLo: 916 mg/kg. Oral (human-woman); TDLo: 2700 mg/kg. Oral (human-woman); TDLo: 3240 mg/kg. Oral (rat); TDLo: 10530 mg/kg. Oral (rat); TDLo: 822 mg/kg. Oral (rat); TDLo: 922 mg/kg. Oral (rat); TDLo: 300 mg/kg. Oral (hamster); TDLo: 6300 mg/kg. Oral (Mammal-species unspecified); TDLo: 294 mg/kg. Oral (Mammal-species unspecified); TDLo: 1177 mg/kg. Cytogenetic analysis; rat Ascites tumor: 500 mg/kg. |
| Carcinogenic Effects: | no data |
| Mutagenic Effects: | Insufficient data |
| Tetratogenic Effects: | Reproductive effector |
| SECTION 12: Ecological Information | |
|---|---|
| Ecological Information: | No information available |
| SECTION 13: Disposal Considerations | |
|---|---|
| Disposal: | Dispose of according to local, state and federal regulations. |
| SECTION 14: Transportation | |
|---|---|
| Shipping Name (CFR): | Non-hazardous |
| Hazard Class (CFR): | NA |
| Additional Hazard Class (CFR): | NA |
| Packaging Group (CFR): | NA |
| UN ID Number (CFR): | NA |
| Shipping Name (IATA): | Non-hazardous |
| Hazard Class (IATA): | NA |
| Additional Hazard Class (IATA): | NA |
| Packaging Group (IATA): | NA |
| UN ID Number (IATA): | NA |
| SECTION 15: Regulatory Information | |
|---|---|
| TSCA: | Listed in the TSCA inventory |
| SARA (Title 313): | Title compound not listed |
| Second Ingredient: | none |
| Third Ingredient: | none |
| SECTION 16: Other Information | |
|---|---|
| Disclaimer: | The information herein is believed to be accurate and reliable as of the date compiled. However, Strem Chemicals, Inc. makes no representation, warranty, or guarantee of any kind with respect to the information contained in this document or any use of the product based on this information. |
| Preparation Date: | 6/11/2001 |
| Revision Date: | 12/20/2011 |
